Cliquez pour voir le graph
Connexions
Cliquez pour voir la ligne de temps
Ligne de temps
Cours
Viral Hepatitis MOOC
In this MOOC, you will find the latest developments on the intimate structure and pathophysiology of hepatic viruses, as well as the epidemiology and clinical courses of hepatitis. Register on : https://www.fun-mooc.fr/en/courses/viral-hepatitis/ Hepatitis is an […]
2024-04-09 08:00:00
2025-04-08 20:00:00
Europe/Paris
Viral Hepatitis MOOC
In this MOOC, you will find the latest developments on the intimate structure and pathophysiology of hepatic viruses, as well as the epidemiology and clinical courses of hepatitis. Register on : https://www.fun-mooc.fr/en/courses/viral-hepatitis/ Hepatitis is an […]
Projets
Publications
Télécharger-
2024The HEPSANET score to assess treatment eligibility of chronic hepatitis B in Africa – Authors’ reply., Lancet Gastroenterol Hepatol 2024 Jul; 9(7): 589-590.
-
2024Costs of integrating hepatitis B screening and antiviral prophylaxis into routine antenatal care in Burkina Faso: Treat all versus targeted strategies., Int J Gynaecol Obstet 2024 Jul; 166(1): 44-61.
-
2024A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir., J Clin Virol 2024 Jun; 174(): 105711.
-
2024TREAT-B or Treat All: time for a broader vision on hepatitis B elimination – Author’s reply., Lancet Glob Health 2024 Jun; 12(6): e917.
-
2024Assessment of fever screening at airports in detecting domestic passengers infected with SARS-CoV-2, 2020-2022, Okinawa prefecture, Japan., BMC Infect Dis 2024 May; 24(1): 542.
-
2024Development and evaluation of a simple treatment eligibility score (HEPSANET) to decentralise hepatitis B care in Africa: a cross-sectional study., Lancet Gastroenterol Hepatol 2024 Apr; 9(4): 323-332.
-
2024Simplified Criteria to Assess Long-Term Antiviral Treatment Indication in Chronic HBV-Infected Pregnant Women in Cambodia., Viruses 2024 Jan; 16(2): .
-
2024Proportion of HBV-infected pregnant women eligible for antiviral prophylaxis to prevent vertical transmission: a systematic review and meta-analysis, JHEP Reports Innovation in Hepatology, 2024, 6 (8), pp.101064. ⟨10.1016/j.jhepr.2024.101064⟩.
-
2024Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis., Lancet Glob Health 2024 Jan; 12(1): e66-e78.
-
2023A global research priority agenda to advance public health responses to fatty liver disease., J Hepatol 2023 Sep; 79(3): 618-634.
-
+Voir la liste complète de publications